184 related articles for article (PubMed ID: 17975844)
1. Effects of different molecular weight hyaluronan products on the expression of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
Hsieh YS; Yang SF; Lue KH; Chu SC; Lu KH
J Orthop Res; 2008 Apr; 26(4):475-84. PubMed ID: 17975844
[TBL] [Abstract][Full Text] [Related]
2. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
Yang SF; Hsieh YS; Lue KH; Chu SC; Chang IC; Lu KH
Clin Biochem; 2008 Jan; 41(1-2):109-16. PubMed ID: 17996201
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine sulfate suppresses the expressions of urokinase plasminogen activator and inhibitor and gelatinases during the early stage of osteoarthritis.
Chu SC; Yang SF; Lue KH; Hsieh YS; Lee CY; Chou MC; Lu KH
Clin Chim Acta; 2006 Oct; 372(1-2):167-72. PubMed ID: 16756968
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Wu CL; Lu KH
Connect Tissue Res; 2004; 45(3):142-50. PubMed ID: 15512768
[TBL] [Abstract][Full Text] [Related]
8. Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis.
Chu SC; Yang SF; Lue KH; Hsieh YS; Li TJ; Lu KH
Clin Chim Acta; 2008 Jan; 387(1-2):90-6. PubMed ID: 17963739
[TBL] [Abstract][Full Text] [Related]
9. Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement.
Hsieh YS; Yang SF; Chu SC; Chen PN; Chou MC; Hsu MC; Lu KH
Arthroscopy; 2004 May; 20(5):482-8. PubMed ID: 15122138
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
[TBL] [Abstract][Full Text] [Related]
11. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E
Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818
[TBL] [Abstract][Full Text] [Related]
14. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
15. [Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteroarthritis].
Xu HT; Chen Y; Chen LK; Li JY; Zhang W; Wu B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):47-52. PubMed ID: 18245904
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.
Diehl P; Hantke B; Hennig M; Tschesche H; Mittelmeier W; Schmitt M; Muehlenweg B
Int J Mol Med; 2004 May; 13(5):711-5. PubMed ID: 15067375
[TBL] [Abstract][Full Text] [Related]
17. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
Chang DI; Hosomi N; Lucero J; Heo JH; Abumiya T; Mazar AP; del Zoppo GJ
J Cereb Blood Flow Metab; 2003 Dec; 23(12):1408-19. PubMed ID: 14663336
[TBL] [Abstract][Full Text] [Related]
18. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
[TBL] [Abstract][Full Text] [Related]
19. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage.
Tajima T; Yoshida E; Yamashita A; Ohmura S; Tomitaka Y; Sugiki M; Asada Y; Maruyama M
J Orthop Res; 2005 Jul; 23(4):891-8. PubMed ID: 16023005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
